A randomised, open label, prospective, two arms, parallel group study to evaluate the effectiveness, safety and tolerability of Dhathri Hair Care Cream in comparison with Regular Hair Cream in the management of alopecia and seborrheic dermatitis of the scalp in adults.

Dhathri Ayurveda Private Limited0 个研究点目标入组 36 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Subjects between the age group of 21 to 45 years.
•2. Subjects who are able to give written informed consent and ready to comply with the protocol.
•3. Subjects with active alopecia, and seborrheic dermatitis of the scalp â?? â??Total ASFS Score >= 16
•4. Subjects with a minimum hair length of 2 inches and willing to maintain the same minimum length, hair style until the end of the study.

•1. Subjects on topical treatment for alopecia and seborrheic dermatitis for 4 weeks prior to enrollment.
•2. Subject with other dermatological disorders of the scalp that might interfere with the study evaluation.
•3. Subjects with significant scalp scarring.
•4. Subjects who have anemia or iron deficiency.
•5. Subjects who have previously undergone hair transplantation procedures.
•6. History of systemic or cutaneous malignancy or evidence of immunocompromised state.
•7. Subjects with history of skin allergy.
•8. Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
•9. Female subjects who are reported pregnant/planning a pregnancy or lactating.
•10. Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrollment.
•11. Subjects, who in the opinion of the Investigator or the Expert Dermatologist are not eligible for enrollment in the study.

发起方